SPIOMET

DRUG2 trials

Sponsors

Fundacio Sant Joan De Deu, Hospital Universitari De Girona Doctor Josep Trueta

Conditions

Girls with advanced puberty and accelerated bone maturation. Polycystic Ovary Syndrome (PCOS)Polycystic ovary syndrome (PCOS)

Phase 2

Towards a treatment for accelerated maturation in girls testing spiomet in a randomised placebo controlled, multicentre study.

Active, not recruitingCTIS2024-518675-55-00

Hospital Universitari De Girona Doctor Josep TruetaGirls with advanced puberty and accelerated bone maturation. Polycystic Ovary Syndrome (PCOS)

Start: 2022-12-02Target: 64Updated: 2024-10-28

A Phase II, randomised, multi-centric, multi-national clinical trial to evaluate the efficacy, tolerability, and safety of a fixed dose combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) for adolescent girls and young adult women (AYAs) with polycystic ovary syndrome (PCOS).

Active, not recruitingCTIS2024-518527-29-00

Fundacio Sant Joan De DeuPolycystic ovary syndrome (PCOS)

Start: 2022-05-24Target: 316Updated: 2025-11-13